July 25, 2019

FDA issues final guidance for drug-device combo products

By: Judy Mathias
Share

Editor’s Note

The Food & Drug Administration (FDA) on July 22 issued a final guidance for makers of products that combine devices and drugs or biologics.

The guidance clarifies how manufacturers should comply with recordkeeping requirements and how they should submit safety reports and avoid duplication.

Episode of Care: Managing the Unique Supply Chain Needs of the ASC
You may also be interested in this session at the OR Manager Conference

After this session you'll be able to: 1. Compare and contrast the traditional ambulatory surgery center with a multi-licensed facility. 2. Describe the unique supply chain needs of a multi-licensed…
Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat